Dishman Carbogen Amcis Ltd. Financials

NSE BSE

15:52 Jul 18

Dishman Carbogen Amcis Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

260.35

-3.55 (-1.35%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

260.35

-3.55 (-1.35%)
15:52 Jul 18

Quality

84/100
High Financial Strength

Valuation

53/100
Affordable Valuation

Technical

66/100
Technically Moderately Bullish

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Net Sales	1912.03	2140.69	2412.92	2615.77	2711.5
Operating Expenses +	1637.68	1809.32	2080.72	2329.27	2242.56
Raw Material	434.77	460.5	624.99	601.21	592.96
Increase Decrease in Cost	33.38	-13.08	-113.58	-4.02	-91.31
Other Manufacturing Expense	14.94	9.87	23.6	11.41	0
Employee Cost	872.91	981.49	1035.27	1208.16	1293.57
Miscellaneous Expenses	281.68	370.54	510.44	512.51	447.34
Operating Profit	274.35	331.37	332.2	286.5	468.94
Other Income	38.45	43.42	27.77	28.21	21.68
Depreciation	307.94	307.59	280.72	310.86	293.74
Interest	47.61	56.81	85.69	119.97	159.46
Profit before tax and exceptio..	-42.75	10.39	-6.44	-116.12	37.42
Exceptional Items	-22.28	-14.64	-48.15	-6.14	-18.11
PBT	-65.03	-4.25	-54.59	-122.26	19.31
Provision for Taxation	100.1	-22.26	-24.79	31.19	16.07
Net Profit	-165.13	18.01	-29.8	-153.45	3.24
NET Profit after MI	-165.13	18.01	-29.8	-153.45	3.24
EPS	-10.53	1.15	-1.9	-9.79	0.21
Operating Profit Margin (%)	14.35	15.48	13.77	10.95	17.29
Net Profit Margin (%)	-8.64	0.84	-1.24	-5.87	0.12

All Data in Percentage (%)

	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24
Promoter	59.30	59.30	59.30	59.30	59.30
FII	9.50	8.80	8.20	8.00	8.70
MF	1.10	1.20	1.00	1.30	2.20
Others	0.20	0.20	0.20	0.20	0.20

Promoter Non-Promoter

Shareholder	Shares	Holding %

Download Our App On: